Concepts (232)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Antineoplastic Agents | 10 | 2016 | 803 | 1.670 |
Why?
|
| Colorectal Neoplasms | 6 | 2024 | 441 | 1.570 |
Why?
|
| Sulfones | 4 | 2015 | 44 | 1.190 |
Why?
|
| MicroRNAs | 2 | 2024 | 426 | 1.150 |
Why?
|
| Colonoscopy | 4 | 2016 | 104 | 1.070 |
Why?
|
| Colonic Neoplasms | 7 | 2012 | 186 | 1.050 |
Why?
|
| Adenomatous Polyposis Coli | 7 | 2018 | 27 | 0.960 |
Why?
|
| Acrylonitrile | 2 | 2015 | 3 | 0.930 |
Why?
|
| Peritoneal Neoplasms | 3 | 2012 | 16 | 0.890 |
Why?
|
| Receptor, erbB-2 | 3 | 2012 | 133 | 0.830 |
Why?
|
| Gastrointestinal Hemorrhage | 3 | 2007 | 27 | 0.800 |
Why?
|
| Hedgehog Proteins | 2 | 2014 | 50 | 0.750 |
Why?
|
| Carcinoma | 2 | 2012 | 96 | 0.750 |
Why?
|
| Intestinal Mucosa | 2 | 2014 | 122 | 0.730 |
Why?
|
| Nitriles | 3 | 2012 | 69 | 0.700 |
Why?
|
| Apoptosis | 9 | 2015 | 1398 | 0.670 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2018 | 182 | 0.620 |
Why?
|
| Health Personnel | 1 | 2020 | 228 | 0.610 |
Why?
|
| Early Detection of Cancer | 2 | 2024 | 336 | 0.600 |
Why?
|
| Primary Health Care | 1 | 2020 | 294 | 0.590 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2020 | 807 | 0.580 |
Why?
|
| Adenoma | 5 | 2010 | 89 | 0.560 |
Why?
|
| Microfilament Proteins | 2 | 2014 | 69 | 0.560 |
Why?
|
| Duodenal Neoplasms | 1 | 2016 | 4 | 0.550 |
Why?
|
| Ovarian Neoplasms | 3 | 2015 | 312 | 0.550 |
Why?
|
| Antibodies, Monoclonal | 3 | 2007 | 290 | 0.530 |
Why?
|
| Pancreatic Neoplasms | 2 | 2015 | 111 | 0.530 |
Why?
|
| Rectal Diseases | 2 | 2005 | 4 | 0.520 |
Why?
|
| Receptors, Death Domain | 2 | 2011 | 2 | 0.490 |
Why?
|
| Peutz-Jeghers Syndrome | 2 | 2011 | 2 | 0.470 |
Why?
|
| Drug Design | 1 | 2015 | 162 | 0.460 |
Why?
|
| Humans | 32 | 2024 | 37093 | 0.450 |
Why?
|
| Neoplasms | 4 | 2012 | 1103 | 0.450 |
Why?
|
| Mass Screening | 1 | 2016 | 462 | 0.400 |
Why?
|
| CASP8 and FADD-Like Apoptosis Regulating Protein | 1 | 2011 | 8 | 0.400 |
Why?
|
| Histones | 1 | 2012 | 190 | 0.380 |
Why?
|
| Mice | 10 | 2015 | 5913 | 0.360 |
Why?
|
| Female | 17 | 2020 | 20969 | 0.350 |
Why?
|
| Gene Expression Regulation | 2 | 2014 | 1015 | 0.350 |
Why?
|
| Clinical Trials as Topic | 2 | 2011 | 204 | 0.350 |
Why?
|
| Hawaii | 3 | 2020 | 1929 | 0.320 |
Why?
|
| Down-Regulation | 3 | 2011 | 435 | 0.310 |
Why?
|
| Mice, Nude | 5 | 2012 | 337 | 0.310 |
Why?
|
| Family | 2 | 2010 | 173 | 0.310 |
Why?
|
| Gastrostomy | 1 | 2007 | 7 | 0.300 |
Why?
|
| Foreign Bodies | 1 | 2007 | 6 | 0.300 |
Why?
|
| Animals | 12 | 2015 | 15081 | 0.290 |
Why?
|
| Enteral Nutrition | 1 | 2007 | 16 | 0.290 |
Why?
|
| Gene Deletion | 2 | 2010 | 166 | 0.290 |
Why?
|
| Deglutition Disorders | 1 | 2007 | 19 | 0.290 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2007 | 59 | 0.280 |
Why?
|
| Malnutrition | 1 | 2006 | 44 | 0.270 |
Why?
|
| Cell Proliferation | 5 | 2015 | 1198 | 0.270 |
Why?
|
| Follow-Up Studies | 5 | 2020 | 974 | 0.270 |
Why?
|
| Middle Aged | 10 | 2020 | 10129 | 0.260 |
Why?
|
| Integrin alpha5beta1 | 1 | 2005 | 5 | 0.260 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2008 | 628 | 0.260 |
Why?
|
| Cell Line, Tumor | 5 | 2015 | 2231 | 0.260 |
Why?
|
| Colonic Diseases | 1 | 2004 | 11 | 0.250 |
Why?
|
| Genes, APC | 3 | 2016 | 14 | 0.250 |
Why?
|
| Male | 13 | 2020 | 20025 | 0.240 |
Why?
|
| Caco-2 Cells | 3 | 2012 | 52 | 0.240 |
Why?
|
| Sulindac | 3 | 2018 | 9 | 0.240 |
Why?
|
| Feces | 1 | 2024 | 111 | 0.230 |
Why?
|
| HT29 Cells | 2 | 2015 | 45 | 0.230 |
Why?
|
| Cell Adhesion | 3 | 2011 | 212 | 0.220 |
Why?
|
| Signal Transduction | 6 | 2014 | 1908 | 0.220 |
Why?
|
| Organic Chemicals | 1 | 2002 | 35 | 0.210 |
Why?
|
| Anti-Infective Agents | 1 | 2002 | 64 | 0.210 |
Why?
|
| Aged | 6 | 2020 | 6741 | 0.200 |
Why?
|
| Retrospective Studies | 4 | 2016 | 2026 | 0.200 |
Why?
|
| RNA, Messenger | 3 | 2014 | 1207 | 0.190 |
Why?
|
| Structure-Activity Relationship | 2 | 2015 | 409 | 0.180 |
Why?
|
| Neoplasm Transplantation | 3 | 2012 | 122 | 0.180 |
Why?
|
| Prognosis | 2 | 2020 | 739 | 0.180 |
Why?
|
| Liver Cirrhosis | 1 | 2020 | 52 | 0.180 |
Why?
|
| Japan | 1 | 2020 | 305 | 0.180 |
Why?
|
| NF-kappa B | 1 | 2002 | 339 | 0.180 |
Why?
|
| Neoplasm Seeding | 2 | 2013 | 5 | 0.170 |
Why?
|
| Risk Reduction Behavior | 1 | 2020 | 127 | 0.170 |
Why?
|
| Disease Progression | 2 | 2020 | 601 | 0.160 |
Why?
|
| Cell Division | 2 | 2012 | 307 | 0.150 |
Why?
|
| Cell Differentiation | 2 | 2014 | 587 | 0.150 |
Why?
|
| Case-Control Studies | 1 | 2020 | 1130 | 0.150 |
Why?
|
| Caspases | 2 | 2009 | 147 | 0.140 |
Why?
|
| Adult | 9 | 2018 | 11712 | 0.130 |
Why?
|
| Integrases | 1 | 2014 | 26 | 0.120 |
Why?
|
| Immunoenzyme Techniques | 1 | 2014 | 108 | 0.120 |
Why?
|
| Transfection | 2 | 2006 | 523 | 0.120 |
Why?
|
| Cell Nucleus | 3 | 2012 | 366 | 0.120 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2015 | 1039 | 0.120 |
Why?
|
| Aged, 80 and over | 3 | 2010 | 2379 | 0.110 |
Why?
|
| Catheter Ablation | 1 | 2013 | 30 | 0.110 |
Why?
|
| Liver Diseases | 1 | 2013 | 33 | 0.110 |
Why?
|
| Liver Transplantation | 1 | 2013 | 30 | 0.110 |
Why?
|
| Molecular Structure | 1 | 2015 | 492 | 0.110 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2014 | 623 | 0.110 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2013 | 128 | 0.100 |
Why?
|
| Blotting, Western | 1 | 2014 | 859 | 0.100 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2012 | 42 | 0.100 |
Why?
|
| Peritoneum | 1 | 2012 | 8 | 0.100 |
Why?
|
| Risk Factors | 4 | 2013 | 3562 | 0.100 |
Why?
|
| Coculture Techniques | 1 | 2012 | 101 | 0.100 |
Why?
|
| Mice, Knockout | 1 | 2014 | 933 | 0.100 |
Why?
|
| Phosphorylation | 2 | 2005 | 928 | 0.100 |
Why?
|
| Ovary | 1 | 2012 | 108 | 0.100 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2013 | 145 | 0.100 |
Why?
|
| Epithelium | 1 | 2011 | 79 | 0.100 |
Why?
|
| Liver Neoplasms | 1 | 2013 | 190 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 13 | 1 | 2010 | 11 | 0.090 |
Why?
|
| Cells, Cultured | 1 | 2014 | 1518 | 0.090 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2010 | 59 | 0.090 |
Why?
|
| Promoter Regions, Genetic | 1 | 2012 | 515 | 0.090 |
Why?
|
| Porifera | 1 | 2009 | 8 | 0.090 |
Why?
|
| Alkaloids | 1 | 2009 | 39 | 0.080 |
Why?
|
| RNA, Small Interfering | 1 | 2011 | 409 | 0.080 |
Why?
|
| Imidazoles | 1 | 2009 | 126 | 0.080 |
Why?
|
| Neoplasm Metastasis | 1 | 2009 | 219 | 0.080 |
Why?
|
| Age Distribution | 1 | 2008 | 225 | 0.080 |
Why?
|
| Sex Distribution | 1 | 2008 | 215 | 0.080 |
Why?
|
| Genetic Testing | 2 | 2005 | 75 | 0.070 |
Why?
|
| Hepatocyte Nuclear Factor 3-beta | 1 | 2006 | 1 | 0.070 |
Why?
|
| Gastrointestinal Contents | 1 | 2006 | 2 | 0.070 |
Why?
|
| Enterocytes | 1 | 2006 | 4 | 0.070 |
Why?
|
| TCF Transcription Factors | 1 | 2006 | 15 | 0.070 |
Why?
|
| Microvilli | 1 | 2006 | 9 | 0.070 |
Why?
|
| Rats | 1 | 2014 | 3483 | 0.070 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 2006 | 17 | 0.070 |
Why?
|
| Ki-67 Antigen | 1 | 2006 | 33 | 0.070 |
Why?
|
| Macular Degeneration | 1 | 2007 | 29 | 0.070 |
Why?
|
| Hyperplasia | 1 | 2006 | 38 | 0.070 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2007 | 161 | 0.070 |
Why?
|
| Intestines | 1 | 2006 | 64 | 0.070 |
Why?
|
| United States | 2 | 2008 | 4223 | 0.070 |
Why?
|
| Colorectal Neoplasms, Hereditary Nonpolyposis | 1 | 2006 | 18 | 0.070 |
Why?
|
| Mitochondria | 1 | 2010 | 487 | 0.070 |
Why?
|
| Hamartoma Syndrome, Multiple | 1 | 2005 | 2 | 0.070 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2006 | 187 | 0.070 |
Why?
|
| Agar | 1 | 2005 | 8 | 0.060 |
Why?
|
| Biotinylation | 1 | 2005 | 11 | 0.060 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2005 | 29 | 0.060 |
Why?
|
| Fissure in Ano | 1 | 2004 | 1 | 0.060 |
Why?
|
| Hemorrhoids | 1 | 2004 | 1 | 0.060 |
Why?
|
| Hemostasis, Endoscopic | 1 | 2004 | 2 | 0.060 |
Why?
|
| Ulcer | 1 | 2004 | 5 | 0.060 |
Why?
|
| Intestinal Polyps | 1 | 2004 | 4 | 0.060 |
Why?
|
| Diverticulum, Colon | 1 | 2004 | 3 | 0.060 |
Why?
|
| Angiodysplasia | 1 | 2004 | 3 | 0.060 |
Why?
|
| Blotting, Northern | 1 | 2005 | 150 | 0.060 |
Why?
|
| Tumor Cells, Cultured | 2 | 2003 | 502 | 0.060 |
Why?
|
| Immunoprecipitation | 1 | 2005 | 131 | 0.060 |
Why?
|
| Medical Records | 1 | 2004 | 41 | 0.060 |
Why?
|
| Immunoblotting | 1 | 2005 | 176 | 0.060 |
Why?
|
| Cytoplasm | 1 | 2005 | 143 | 0.060 |
Why?
|
| Mice, Transgenic | 1 | 2006 | 617 | 0.060 |
Why?
|
| Lysosomes | 1 | 2005 | 91 | 0.060 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2005 | 188 | 0.060 |
Why?
|
| Green Fluorescent Proteins | 1 | 2005 | 208 | 0.060 |
Why?
|
| Extracellular Matrix | 1 | 2005 | 115 | 0.060 |
Why?
|
| Adenomatous Polyposis Coli Protein | 1 | 2004 | 9 | 0.060 |
Why?
|
| Epidermal Growth Factor | 1 | 2004 | 68 | 0.060 |
Why?
|
| Colitis | 1 | 2004 | 65 | 0.060 |
Why?
|
| Protein Structure, Tertiary | 1 | 2005 | 408 | 0.060 |
Why?
|
| Introns | 1 | 2004 | 75 | 0.060 |
Why?
|
| Prevalence | 1 | 2008 | 1455 | 0.060 |
Why?
|
| Ubiquitin | 1 | 2004 | 78 | 0.060 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2004 | 132 | 0.060 |
Why?
|
| Abdominal Neoplasms | 1 | 2002 | 3 | 0.060 |
Why?
|
| Transplantation, Heterologous | 1 | 2002 | 90 | 0.050 |
Why?
|
| Cell Membrane | 1 | 2005 | 381 | 0.050 |
Why?
|
| Cytoskeletal Proteins | 1 | 2003 | 105 | 0.050 |
Why?
|
| Trans-Activators | 1 | 2003 | 174 | 0.050 |
Why?
|
| Jews | 1 | 2002 | 5 | 0.050 |
Why?
|
| Adenomatous Polyps | 1 | 2002 | 12 | 0.050 |
Why?
|
| Transcription, Genetic | 1 | 2005 | 578 | 0.050 |
Why?
|
| Age Factors | 1 | 2004 | 1033 | 0.050 |
Why?
|
| Breast Neoplasms | 1 | 2012 | 1502 | 0.050 |
Why?
|
| Treatment Outcome | 2 | 2018 | 1369 | 0.050 |
Why?
|
| Time Factors | 1 | 2005 | 1742 | 0.050 |
Why?
|
| Phenotype | 3 | 2010 | 689 | 0.040 |
Why?
|
| Utah | 2 | 2010 | 9 | 0.040 |
Why?
|
| Pedigree | 2 | 2010 | 79 | 0.040 |
Why?
|
| Colectomy | 2 | 2004 | 16 | 0.030 |
Why?
|
| Needles | 1 | 2013 | 9 | 0.030 |
Why?
|
| Survival Rate | 1 | 2013 | 311 | 0.030 |
Why?
|
| Adamantane | 1 | 2010 | 8 | 0.020 |
Why?
|
| Hepatocyte Nuclear Factor 4 | 1 | 2010 | 5 | 0.020 |
Why?
|
| Cinnamates | 1 | 2010 | 6 | 0.020 |
Why?
|
| Cell Respiration | 1 | 2010 | 35 | 0.020 |
Why?
|
| Cytochromes c | 1 | 2010 | 53 | 0.020 |
Why?
|
| Databases, Genetic | 1 | 2010 | 93 | 0.020 |
Why?
|
| Chromosome Mapping | 1 | 2010 | 188 | 0.020 |
Why?
|
| Protein Stability | 1 | 2010 | 45 | 0.020 |
Why?
|
| Retinoids | 1 | 2010 | 28 | 0.020 |
Why?
|
| Genetic Markers | 1 | 2010 | 142 | 0.020 |
Why?
|
| Haplotypes | 1 | 2010 | 182 | 0.020 |
Why?
|
| Hepatocytes | 1 | 2010 | 75 | 0.020 |
Why?
|
| Neoplasms, Experimental | 1 | 2009 | 37 | 0.020 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2009 | 113 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2010 | 152 | 0.020 |
Why?
|
| Protein Transport | 1 | 2010 | 302 | 0.020 |
Why?
|
| Cell Culture Techniques | 1 | 2009 | 142 | 0.020 |
Why?
|
| Fibroblasts | 1 | 2010 | 272 | 0.020 |
Why?
|
| Cell Cycle | 1 | 2009 | 326 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2010 | 461 | 0.020 |
Why?
|
| Incidental Findings | 1 | 2006 | 10 | 0.020 |
Why?
|
| Back Pain | 1 | 2006 | 19 | 0.020 |
Why?
|
| Abdominal Pain | 1 | 2006 | 24 | 0.020 |
Why?
|
| Protein Binding | 1 | 2010 | 972 | 0.020 |
Why?
|
| DNA Glycosylases | 1 | 2005 | 16 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2006 | 214 | 0.020 |
Why?
|
| Endoscopy, Digestive System | 1 | 2004 | 3 | 0.020 |
Why?
|
| Rectum | 1 | 2004 | 22 | 0.020 |
Why?
|
| Physical Examination | 1 | 2004 | 43 | 0.020 |
Why?
|
| Registries | 1 | 2006 | 335 | 0.020 |
Why?
|
| Family Health | 1 | 2004 | 56 | 0.010 |
Why?
|
| Adolescent | 2 | 2005 | 5363 | 0.010 |
Why?
|
| Leupeptins | 1 | 2003 | 11 | 0.010 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 2003 | 22 | 0.010 |
Why?
|
| Germ-Line Mutation | 1 | 2004 | 57 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2004 | 325 | 0.010 |
Why?
|
| Cysteine Endopeptidases | 1 | 2003 | 59 | 0.010 |
Why?
|
| beta Catenin | 1 | 2003 | 48 | 0.010 |
Why?
|
| Multienzyme Complexes | 1 | 2003 | 69 | 0.010 |
Why?
|
| Caspase 3 | 1 | 2003 | 207 | 0.010 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2003 | 114 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2004 | 448 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2004 | 562 | 0.010 |
Why?
|
| Base Sequence | 1 | 2004 | 997 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2003 | 433 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2004 | 1568 | 0.010 |
Why?
|
| Child | 1 | 2005 | 3131 | 0.010 |
Why?
|